Burges Salmon advises asset management company Premier Asset Management on the admission of its shares to trading on AIM, a market of the London Stock Exchange.
The corporate team from Burges Salmon has advised asset management company Premier Asset Management Group PLC on the admission of its shares to trading on AIM, a market of the London Stock Exchange plc.
DLA Piper has advised Smart-Core Holdings Limited on its successful approximately HK240 million initial public offering in Hong Kong, assuming the over-allotment option is exercised in full.
Smart-Core is a leading distributor of integrated circuit and electronic components headquartered in the PRC. The company believes there will be rapid growth in its field in the future. The Hong Kong tranche was over-subscribed by 15.5 times and the international tranche was moderately over-subscribed.
The Freshfields team advising on the transaction was led by corporate partners Teresa Ko, Calvin Lai and Richard Wang
Freshfields Bruckhaus Deringer LLP (‘Freshfields’) has advised on the US$1.5bn IPO of China Merchants Securities Co. Ltd (‘China Merchants Securities’). Freshfields acted as Hong Kong and US legal counsel to the underwriters China Merchants Securities HK, JPMorgan Securities (Far East) and Morgan Stanley Asia Limited.
Leading international law firm Clifford Chance has advised Maybank Investment Bank Berhad, on Sime Darby Berhad’s US$571 million placement of 316.3 million shares in the largest share placement and equity capital market deal of the year in Malaysia outside of rights offers, and the second largest for 2016 in South East Asia.
The team was led by capital markets partner Raymond Tong, who was supported by senior associates Chong Ying Chiang and Jonathan Crandall.
Vinge has advised a syndicate of banks consisting of ABG Sundal Collier AB and Swedbank AB in connection with the logistics property company Catena AB’s SEK 330 million brokered private placement. Catena is listed on Nasdaq Stockholm.
Vinge’s team consisted of Jesper Schönbeck and David Andersson.
Allen & Overy LLP has advised the real estate investment manager and co-investor CORESTATE Capital Holding S.A. ("CORESTATE") on its successful IPO. On 4 October 2016, the first day of trading, the shares of the company were offered at EUR 17.40 per share in the Entry Standard of the Frankfurt Stock Exchange. With a total of 12,610,681 shares, the company's market capitalisation was thus EUR 219.4m.
Prior to the IPO, CORESTATE had successfully completed a capital increase by way of private placement with selected international investors.
The biotechnology company Zealand Pharma has issued new shares totalling approximately DKK 143m. The shares were offered as an accelerated book-building process. Plesner advised Zealand Pharma on the sale of the shares.
The new increase in the share capital by DKK 143m is to fund Zealand Pharma's continued development of key clinical stage product candidates.
Approximately 2/3 of the new shares were subscribed for by US investors and the remaining 1/3 by European investors.
The Freshfields team is being led by corporate partner Chris Mort
Freshfields Bruckhaus Deringer LLP (‘Freshfields’) has advised ConvaTec on its proposal to raise $1.8 billion through an IPO and listing on the London Stock Exchange. ConvaTec is a global medical products and technologies group which focusses on therapies for the management of chronic conditions.
The Hong Kong office of the Firm represented Honma Golf Limited (“HONMA”) in connection with its initial public offering in Hong Kong and Rule 144A/Regulation S offering of an aggregate of 133,991,000 ordinary shares (prior to the exercise of the overallotment option), which raised approximately HK$1,339.9 million (US$174.2 million) in gross proceeds. The ordinary shares of HONMA are listed on the Hong Kong Stock Exchange. Morgan Stanley Asia Limited acted as the sole sponsor and sole global coordinator.
Macfarlanes has advised mid-market private equity firm Mayfair Equity Partners (Mayfair) on the closure of its first fund at £400m, ahead of its £350m target.
The fund received commitments from investors in Europe, the UK, North America and Asia and will focus on providing growth and buyout capital to technology and consumer businesses.